GloPID-R Network
ANRS Emerging Infectious Diseases is a member of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), a network of European and international funders of research in infectious diseases.
Last updated on 17 December 2024
The essentials
GloPID-R is a network of research funding organizations whose mission is to facilitate the coordination of international funding to improve the preparedness and reactivity of the research response to epidemics and pandemics.
The objectives of GloPID-R
GloPID-R aims to improve the response to epidemics by mobilizing its members to analyse existing knowledge, target priority funding needs, promote data sharing and speed up the allocation of research funds in the event of a crisis. Founded in 2013, the project is funded by the Horizon 2020 research and innovation programme. To date, the network has 35 members and 8 observers spread around the world; Pasteur Network and ANRS MIE are the two French representatives of the network.
The roadmap to promote better coordination of clinical trials in the event of epidemics and pandemics
The GloPID-R Roadmap for Clinical Trial Coordination is now publicly available on the GloPID-R website. With its clear objectives, principles and recommendations, it is a valuable tool for funding bodies and other stakeholders.
A total of three objectives supported by 11 principles, together with a series of recommendations aimed at implementing these principles, were defined through a consultative and iterative approach on a global scale. Researchers and funding agencies from around the world shared their experiences of coordinating clinical trials during epidemics. The recommendations in the roadmap are therefore based on lessons learned.
This roadmap will help to improve the world’s capacity to conduct coordinated, effective and equitable clinical trials in response to epidemics and pandemics.